proline has been researched along with Infections, Respiratory in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Chen, S; Deng, Y; Ge, F; Li, H; Li, W; Ma, L; Qin, B; Wang, J; Wang, Y; Zeng, R; Zheng, B; Zheng, X | 1 |
Alami, NN; Asatryan, A; Burroughs, M; Fredrick, LM; Heo, J; Hou, J; Jia, J; Kalluri, HV; Kim, YJ; Krishnan, P; Lim, SG; Liu, W; Lu, W; Mobashery, N; Tripathi, R; Wang, G; Wei, L; Xie, Q; Xie, W; Zhang, M | 1 |
Axten, JM; Blackledge, CW; Bobko, MA; Campobasso, N; Duquenne, C; Gallagher, TF; Grant, SW; Kulkarni, S; Lewandowski, T; Medina, JR; Miller, WH; Peng, T; Pinckney, T; Van Aller, GS; Ward, P; Zonis, R | 1 |
1 trial(s) available for proline and Infections, Respiratory
Article | Year |
---|---|
Glecaprevir-pibrentasvir to treat chronic hepatitis C virus infection in Asia: two multicentre, phase 3 studies- a randomised, double-blind study (VOYAGE-1) and an open-label, single-arm study (VOYAGE-2).
Topics: Adult; Aged; Aminoisobutyric Acids; Antiviral Agents; Asia; Benzimidazoles; Case-Control Studies; Cyclopropanes; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Leucine; Liver Cirrhosis; Male; Middle Aged; Placebos; Prevalence; Proline; Pyrrolidines; Quinoxalines; Respiratory Tract Infections; Safety; Sulfonamides; Sustained Virologic Response; Treatment Outcome | 2020 |
2 other study(ies) available for proline and Infections, Respiratory
Article | Year |
---|---|
Proline metabolism reprogramming of trained macrophages induced by early respiratory infection combined with allergen sensitization contributes to development of allergic asthma in childhood of mice.
Topics: Allergens; Animals; Asthma; Humans; Hypersensitivity; Macrophages; Mice; Mice, Inbred BALB C; Ovalbumin; Proline; Respiratory Syncytial Virus Infections; Respiratory Tract Infections | 2022 |
Acylprolinamides: a new class of peptide deformylase inhibitors with in vivo antibacterial activity.
Topics: Administration, Oral; Amides; Amidohydrolases; Animals; Anti-Bacterial Agents; Bacterial Proteins; Crystallography, X-Ray; Disease Models, Animal; Haemophilus influenzae; Humans; Injections, Intravenous; Microbial Sensitivity Tests; Models, Molecular; Proline; Rats; Respiratory Tract Infections; Streptococcus pneumoniae; Structure-Activity Relationship | 2012 |